Slack Capital interview: Damien Perriman, CCO
investorpress clippingsvideo
Slack Capital interview: Damien Perriman, CCOMay 20, 2025
Michael Heltzen & Erum Azeez Khan
heltzenpress releaseinvestorpress clippings
Podcast: eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on 'Grow Everything'May 16, 2025
Tyler Korman
investorpress clippingsvideo
Slack Capital interview: Tyler Korman, VP of ResearchMay 15, 2025
Transcript: eXoZymes 1st quarter 2025 and NCTx subsidiary update
investor
Transcript: eXoZymes 1st quarter 2025 and NCTx subsidiary updateMay 14, 2025
Slack Capital: EXOZ investment report and CEO interview
heltzeninvestorpress clippingsvideo
Slack Capital: EXOZ investment report and CEO interviewMay 13, 2025
eXoZymes provides first quarter 2025 and NCTx subsidiary update at 5PM EST today
press releaseinvestor
eXoZymes provides first quarter 2025 and NCTx subsidiary update at 5PM EST todayMay 12, 2025
eXoZymes to host first quarter 2025 and subsidiary NCTx update on Monday May 12, 2025, at 5PM EST
press releaseinvestor
eXoZymes to host first quarter 2025 and subsidiary NCTx update on Monday May 12, 2025, at 5PM ESTMay 7, 2025
eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver health
press releaseinvestornutraceuticalsmedicinescience
eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver healthMay 6, 2025
AI transforming biotechnology: From form with AlphaFold to function with exozymes
investorvideoscience
AI transforming biotechnology: From form with AlphaFold to function with exozymesApril 28, 2025
Dr. Tyler Korman, co-founder and VP of Research at eXoZymes, is excited about the 'exozymes' cover story in GEN Biotechnology, which is freely available as an Open Access paper.
press releaseinvestorvideoscience
GEN Biotechnology cover story: Bringing clarity and precision to the cell-free space by introducing exozymesApril 21, 2025
Previous page
Page 5 of 11
Next page